LONDON and NEW YORK - OKYO Pharma Limited (NASDAQ: OKYO), a $36.54 million market cap biotechnology company currently trading at $1.04 per share, engaged in the development of treatments for ocular ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

Kentuckians can't get mifepristone to treat miscarriages because of state anti-abortion law, FDA regulation and confusion ...

A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

J&J on Tuesday said the green light makes Spravato the first and only monotherapy for adults with major depressive disorder who have had an inadequate response to at least two oral antidepressants.

Sepsis, the leading cause of death in U.S. hospitals killing about 350,000 people annually, is an extreme response to an ...

It turns out, your protein powder might not be as healthy as you think.A new report from the Clean Label Project revea ...

Made from petroleum and chemically known as erythrosine, red dye No. 3 is a synthetic color additive used to give foods and ...

New Jersey has considered legislation that would ban the sale of smoke free nicotine pouches, following in the footsteps of ...

This week, the Food and Drug Administration announced a nationwide ban on “red Dye 3,” a food additive with possible links to ...

We should celebrate this step, but our efforts must continue,” Sen. Kristen Thompson said. “There are still a number of ...